Dividend compounder review
HLN
Haleon plc · LSE · GB
Healthcare · Drug Manufacturers - Specialty & Generic
Score79.90/100
Confidence100.00/100
DecisionWatchlist
RatingHigh Quality Watchlist Candidate
Quality breakdown
Dividend Reliability
10.9 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
20.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
24.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
15.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
10.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years3
Dividend Yield2.13%
Payout Ratio36.8%
Dividend Cut 5YNo
Net Income£1.7B
Free Cash Flow£2.2B
FCF Covers DividendYes
Debt / Equity0.52
P/E17.7
Revenue Growth 5Y0.5%
Net Margin15.1%
ROE10.3%
Price vs Trend-8.2%
3Y Return3.1%
5Y Return6.5%
CurrencyGBP
Review flags
Dividend history is short: 3 completed years.
Less than five years of weekly price history available.
Activity record
Less than five years of weekly price history available.
Score 79.9/100, decision Watchlist.
Payment changed from 2.2 to 4.9.
Recorded dividend payment for Haleon plc.
Payment changed from 4.6 to 2.2.
Recorded dividend payment for Haleon plc.
Payment changed from 2 to 4.6.
Recorded dividend payment for Haleon plc.
Payment changed from 4.2 to 2.
Recorded dividend payment for Haleon plc.
Payment changed from 1.8 to 4.2.
Recorded dividend payment for Haleon plc.
Payment changed from 2.4 to 1.8.
Recorded dividend payment for Haleon plc.
Recorded dividend payment for Haleon plc.